description
Powered by Eupheria Biotech
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
ATCCTTGCTGTGGAGCTCTGGAACACTCTCTAAATTTCCCTCTATTAAAAATCACTGCCCTAACTACACTTCCTCCTTGAGGGAATAGAAATGGACCTTTCTCTGACATAGTTCTTGGCATGGGAGCCAGCCACAAATGAGATTCTGACGTGTCCAGGTTTCTCCTGAGCTCATCTACATAGATTGGTAGACCCTTCCTTTGGATTAGGAAAGATGAGTTTTACCTCTGGTACACTGTCTTGGTAAGCCTGGATGTGACAGACACCTCGGCTCTCCTTGAATAAGAAAGCCAGCAGAACTCTTAAAGCCAGTTGTAGTACGGAGTTGTCAGCACTCACTGAACCTCACTTTACAGGGATAAGAGTGGTGTGGCATTTTAAATACAATGGTATGTTATTGCCAGGGAGTGAGGTACAAGACGATGGCTCATGTCACAGGCCTACCTGATACGGTGTCAGAGAAAGTGGTGGGGAAA
Ensembl | human accession no.
NCBI accession no.
shipped in
ambient
storage temp.
−20°C
Quality Level
General description
MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
存储类别
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
Banu Bayram et al.
Journal of clinical medicine, 9(11) (2020-11-21)
(1) Background: Arthrofibrosis is a common cause of patient debility and dissatisfaction after total knee arthroplasty (TKA). The diversity of molecular pathways involved in arthrofibrosis disease progression suggest that effective treatments for arthrofibrosis may require a multimodal approach to counter
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持